Robert  Leman  to  Humans
                            
                            
                                This is a "connection" page, showing publications  Robert  Leman  has written about  Humans.
                            
                            
                            
                                
                                    
                                            
    
        
        
        
            Connection Strength
            
                
            
            0.137
         
        
        
     
 
    
        
        - 
            Clinical trials update: sudden cardiac death prevention by implantable device therapy. Crit Care Nurs Clin North Am. 2005 Mar; 17(1):33-8, x.
            
            
                Score: 0.009
            
         
        
        - 
            Treatment of coronary artery disease in hemodialysis patients: PTCA vs. stent. Catheter Cardiovasc Interv. 2001 Dec; 54(4):459-63.
            
            
                Score: 0.007
            
         
        
        - 
            Significant complications can occur with ischemic heart disease and tilt table testing. Pacing Clin Electrophysiol. 1999 Apr; 22(4 Pt 1):675-7.
            
            
                Score: 0.006
            
         
        
        - 
            The Effect of Chronic Kidney Disease on Mortality with Cardiac Resynchronization Therapy. Pacing Clin Electrophysiol. 2016 Aug; 39(8):863-9.
            
            
                Score: 0.005
            
         
        
        - 
            The impact of device recall on patients and family members of patients with automatic implantable cardioverter defibrillators. Heart Lung. 1994 Jul-Aug; 23(4):317-22.
            
            
                Score: 0.004
            
         
        
        - 
            The effect of left ventricular electrical delay on the acute hemodynamic response with cardiac resynchronization therapy. J Cardiovasc Electrophysiol. 2014 Jun; 25(6):624-30.
            
            
                Score: 0.004
            
         
        
        - 
            Cerebral monitoring during implantation of automatic internal cardiac defibrillators. South Med J. 1993 May; 86(5):533-6.
            
            
                Score: 0.004
            
         
        
        - 
            Safety of continuous anticoagulation with dabigatran during implantation of cardiac rhythm devices. Am J Cardiol. 2013 Apr 15; 111(8):1165-8.
            
            
                Score: 0.004
            
         
        
        - 
            Prosthetic valve endocarditis due to Cardiobacterium hominis occurring after upper gastrointestinal endoscopy. Am J Med. 1991 Apr; 90(4):516-8.
            
            
                Score: 0.004
            
         
        
        - 
            A prospective, randomized comparison of the acute hemodynamic effects of biventricular and left ventricular pacing with cardiac resynchronization therapy. Heart Rhythm. 2011 May; 8(5):685-91.
            
            
                Score: 0.003
            
         
        
        - 
            Defibrillation thresholds in hypertrophic cardiomyopathy. J Cardiovasc Electrophysiol. 2011 May; 22(5):569-72.
            
            
                Score: 0.003
            
         
        
        - 
            Randomized comparison of defibrillation thresholds from the right ventricular apex and outflow tract. Heart Rhythm. 2010 Nov; 7(11):1561-6.
            
            
                Score: 0.003
            
         
        
        - 
            Interventional treatment for ventricular arrhythmias: the initial South Carolina case. J S C Med Assoc. 1990 Jun; 86(6):341-5.
            
            
                Score: 0.003
            
         
        
        - 
            Programming eccentricities of an activity sensing pacemaker. Pacing Clin Electrophysiol. 1990 Jan; 13(1):3-6.
            
            
                Score: 0.003
            
         
        
        - 
            The potential utility of sensor-driven pacing in DDD pacemakers. Am Heart J. 1989 Nov; 118(5 Pt 1):919-23.
            
            
                Score: 0.003
            
         
        
        - 
            Role of transesophageal echocardiography among patients with atrial fibrillation undergoing electrophysiology testing. Am J Cardiol. 2009 Nov 01; 104(9):1256-8.
            
            
                Score: 0.003
            
         
        
        - 
            Supernormal ejection performance is isolated to the ipsilateral congenitally pressure-overloaded ventricle. J Am Coll Cardiol. 1989 May; 13(6):1314-9.
            
            
                Score: 0.003
            
         
        
        - 
            Acute hemodynamic effects of atrial pacing with cardiac resynchronization therapy. J Cardiovasc Electrophysiol. 2009 Aug; 20(8):894-900.
            
            
                Score: 0.003
            
         
        
        - 
            Disparities in preferences for receiving support and education among patients with implantable cardioverter defibrillators. Pacing Clin Electrophysiol. 2009 Mar; 32(3):383-90.
            
            
                Score: 0.003
            
         
        
        - 
            The effect of dofetilide on ventricular defibrillation thresholds. Pacing Clin Electrophysiol. 2009 Jan; 32(1):24-8.
            
            
                Score: 0.003
            
         
        
        - 
            Implantable cardioverter-defibrillator therapy for primary prevention of sudden death after alcohol septal ablation of hypertrophic cardiomyopathy. J Am Coll Cardiol. 2008 Nov 18; 52(21):1718-23.
            
            
                Score: 0.003
            
         
        
        - 
            Effect of data collection method on results of serum digoxin concentration audit. Am J Hosp Pharm. 1988 Jan; 45(1):126-30.
            
            
                Score: 0.003
            
         
        
        - 
            Optimization of superior vena cava coil position and usage for transvenous defibrillation. Heart Rhythm. 2008 Mar; 5(3):394-9.
            
            
                Score: 0.003
            
         
        
        - 
            Predictors of outcome for aortic valve replacement in patients with aortic regurgitation and left ventricular dysfunction: a change in the measuring stick. J Am Coll Cardiol. 1987 Nov; 10(5):991-7.
            
            
                Score: 0.003
            
         
        
        - 
            A prospective comparison of AV delay programming methods for hemodynamic optimization during cardiac resynchronization therapy. J Cardiovasc Electrophysiol. 2007 May; 18(5):490-6.
            
            
                Score: 0.003
            
         
        
        - 
            Resolution of congestive cardiomyopathy caused by supraventricular tachycardia using amiodarone. Am Heart J. 1986 Sep; 112(3):622-4.
            
            
                Score: 0.003
            
         
        
        - 
            Atrial fibrillation among African Americans, Hispanics and Caucasians: clinical features and outcomes from the AFFIRM trial. J Natl Med Assoc. 2006 Mar; 98(3):330-9.
            
            
                Score: 0.002
            
         
        
        - 
            Permanent cardiac pacing in patients on chronic renal dialysis. Am Heart J. 1985 Dec; 110(6):1242-4.
            
            
                Score: 0.002
            
         
        
        - 
            Radionuclide evaluation of dual chamber pacing: comparison between variable AV intervals and ventricular pacing. Pacing Clin Electrophysiol. 1985 May; 8(3 Pt 1):408-14.
            
            
                Score: 0.002
            
         
        
        - 
            Relation of initial resting ventricular rate to the ability to achieve and maintain normal sinus rhythm in patients with atrial fibrillation. Am J Cardiol. 2005 Mar 01; 95(5):597-602.
            
            
                Score: 0.002
            
         
        
        - 
            Time to resumption of driving after implantation of an automatic defibrillator (from the Dual chamber and VVI Implantable Defibrillator [DAVID] trial). Am J Cardiol. 2005 Mar 01; 95(5):665-6.
            
            
                Score: 0.002
            
         
        
        - 
            Efficacy of transthoracic cardioversion of atrial fibrillation using a biphasic, truncated exponential shock waveform at variable initial shock energies. Am J Cardiol. 2004 Dec 15; 94(12):1572-4.
            
            
                Score: 0.002
            
         
        
        - 
            Effectiveness of rapid atrial pacing for termination of drug refractory atrial fibrillation: results of a dual chamber implantable cardioverter defibrillator trial. Card Electrophysiol Rev. 2003 Dec; 7(4):341-4.
            
            
                Score: 0.002
            
         
        
        - 
            Clinical investigation of a new dual-chamber implantable cardioverter defibrillator with improved rhythm discrimination capabilities. J Cardiovasc Electrophysiol. 2003 Feb; 14(2):144-9.
            
            
                Score: 0.002
            
         
        
        - 
            Safety of a single successful conversion of ventricular fibrillation before the implantation of cardioverter defibrillators. Pacing Clin Electrophysiol. 2003 Jan; 26(1P2):483-6.
            
            
                Score: 0.002
            
         
        
        - 
            Myocardial preservation by thrombolytic therapy during acute MI. South Med J. 1983 Jan; 76(1):71-5.
            
            
                Score: 0.002
            
         
        
        - 
            Heart disease and pregnancy. South Med J. 1981 Aug; 74(8):944-6.
            
            
                Score: 0.002
            
         
        
        - 
            Driving with an internal defibrillator: legal, ethical, and quality-of-life issues. J Cardiovasc Nurs. 1997 Jan; 11(2):58-67.
            
            
                Score: 0.001
            
         
        
        - 
            Driving safety among patients with automatic implantable cardioverter defibrillators. JAMA. 1993 Oct 06; 270(13):1587-8.
            
            
                Score: 0.001
            
         
        
        - 
            Anti-oxidized low-density lipoprotein antibodies in patients with coronary heart disease and normal healthy volunteers. Int J Clin Lab Res. 1993; 23(2):95-101.
            
            
                Score: 0.001
            
         
        
        - 
            Chronotropic incompetence: a common and progressive finding in pacemaker patients. Am Heart J. 1992 May; 123(5):1216-9.
            
            
                Score: 0.001
            
         
        
        - 
            Single- versus dual-chamber sensor-driven pacing: comparison of cardiac outputs. Am Heart J. 1991 Sep; 122(3 Pt 1):728-32.
            
            
                Score: 0.001
            
         
        
        - 
            Catheter-induced tricuspid regurgitation. Incidence and clinical significance. Chest. 1991 Mar; 99(3):651-5.
            
            
                Score: 0.001
            
         
        
        - 
            Forceps extraction of permanent pacing leads. Ann Thorac Surg. 1990 Apr; 49(4):676-7.
            
            
                Score: 0.001
            
         
        
        - 
            Pacemaker follow-up and adequacy of Medicare guidelines. Am Heart J. 1988 Jul; 116(1 Pt 1):11-5.
            
            
                Score: 0.001
            
         
        
        - 
            Comparison of lead dislodgment and pocket infection rates after pacemaker implantation in the operating room versus the catheterization laboratory. Am Heart J. 1988 May; 115(5):1048-51.
            
            
                Score: 0.001
            
         
        
        - 
            Efficacy and safety of sustained-release diltiazem as replacement therapy for beta blockers and diuretics for stable angina pectoris and coexisting essential hypertension: a multicenter trial. Am J Cardiol. 1987 Dec 14; 60(17):29I-35I.
            
            
                Score: 0.001
            
         
        
        - 
            Association of a porcine mitral valve with development of a left ventricular aneurysm. J S C Med Assoc. 1987 Sep; 83(9):485-6.
            
            
                Score: 0.001
            
         
        
        - 
            Limitations of the long-term clinical application of rate hysteresis. Pacing Clin Electrophysiol. 1987 Mar; 10(2):302-4.
            
            
                Score: 0.001
            
         
        
        - 
            An argument for pacemaker reuse: pacemaker mortality in 169 patients over ten years. Pacing Clin Electrophysiol. 1986 Nov; 9(6 Pt 2):1295-8.
            
            
                Score: 0.001
            
         
        
        - 
            Use of combined calcium channel blockers for therapy of refractory angina pectoris. J S C Med Assoc. 1986 Feb; 82(2):65-8.
            
            
                Score: 0.001
            
         
        
        - 
            Steroid treatment of the painful pacemaker pocket. Pacing Clin Electrophysiol. 1984 Jan; 7(1):71-3.
            
            
                Score: 0.001
            
         
        
        - 
            Cardiac pacing under hyperbaric conditions. Ann Thorac Surg. 1983 Jul; 36(1):66-8.
            
            
                Score: 0.001